Tuberculous pleurisy after tumour necrosis factor-? antagonist usage: Case report

Basit Öğe Kaydı
dc.authorscopusid12243377000
dc.authorscopusid14064610300
dc.authorscopusid15923079600
dc.authorscopusid15921923000
dc.authorscopusid6507404390
dc.contributor.authorAko?lu, Sebahat
dc.contributor.authorBabayi?it, Cenk
dc.contributor.authorKarazincir, Sinem
dc.contributor.authorBalcı, Ali
dc.contributor.authorHanta, Ismail
dc.date.accessioned2024-09-19T15:48:35Z
dc.date.available2024-09-19T15:48:35Z
dc.date.issued2008
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractA thirty-six year old male patient presented with dyspnea, right-sided chest pain, night sweats and intermittent fever. He has a history of ankylosing spondylitis treated with tumour necrosis factor-alpha (TNF-?) antagonist (infliximab). Computed tomography of the chest showed mediastinal lymphadenopathy, right-sided pleural effusion, and atelectasis. The pleural fluid was exudative with lymphocyte dominance. Closed pleural biopsy was nondiagnostic. The adenosine deaminase level of the pleural fluid was 110 U/L. In light of these findings, the patient was diagnosed as tuberculous pleurisy and antituberculous treatment was given. After one month, pleural fluid was markedly reduced.en_US
dc.identifier.endpage452en_US
dc.identifier.issn0494-1373
dc.identifier.issue4en_US
dc.identifier.pmid19123083en_US
dc.identifier.scopus2-s2.0-58149154487en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage448en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12483/15180
dc.identifier.volume56en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isotren_US
dc.relation.ispartofTuberkuloz ve Toraksen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectInfliximaben_US
dc.subjectTNF antagonisten_US
dc.subjectTuberculosisen_US
dc.subjectTumour necrosis factoren_US
dc.titleTuberculous pleurisy after tumour necrosis factor-? antagonist usage: Case reporten_US
dc.title.alternativeTümör nekroz faktörü-? antagonisti kullanimi sonrasi gelişen tüberküloz plörezi: Olgu sunumuen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu